In addition to PTCH1, SUFU, TP53 and APC, recent medulloblastoma studies have identified germline pathogenic or likely pathogenic (P/LP) variants in a few well described cancer susceptibility genes (CSG), including ELP1 and GPR161 (13–17). This evidence concerns the gene TP53 and medulloblastoma.